Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study.

Vafaei, Rana; Samadi, Mitra; Hosseinzadeh, Aysooda; Barzaman, Khadijeh; Esmailinejad, MohammadReza; Khaki, Zohreh; Farahmand, Leila

Vafaei, Rana; Samadi, Mitra; Hosseinzadeh, Aysooda; Barzaman, Khadijeh; Esmailinejad, MohammadReza; Khaki, Zohreh; Farahmand, Leila.

Afiliación

Vafaei R; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, No.146, South Gandi Ave, Vanak Sq, Tehran, Iran.
Samadi M; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, No.146, South Gandi Ave, Vanak Sq, Tehran, Iran.
Hosseinzadeh A; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, No.146, South Gandi Ave, Vanak Sq, Tehran, Iran.
Barzaman K; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, No.146, South Gandi Ave, Vanak Sq, Tehran, Iran.
Esmailinejad M; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Khaki Z; Department of Surgery and Radiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Farahmand L; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, No.146, South Gandi Ave, Vanak Sq, Tehran, Iran. zkhaki@ut.ac.ir.

Cancer Cell Int ; 22(1): 14, 2022 Jan 09.

Article en En | MEDLINE | ID: mdl-35000604

Palabras clave

Canine mammary tumor; Immunotherapy; Mucin-1; Preclinical trials

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google